In The News

In Bloomberg Law, Health Care Attorneys Examine EU GDPR Implications for Scientific

Practices: Health Care, Life Sciences, FDA Regulatory, Clinical Research, Health Privacy & Security, General Data Protection Regulation

Final guidelines on consent requirements under the European Union’s General Data Protection Regulation were recently released by an EU advisory body.

Health care partner Mark Barnes and associate David Peloquin (both of Boston), and health care associate Nicholas Wallace (San Francisco) co-authored an April 30 article in Bloomberg Law’s Life Sciences Law & Industry Report that provides an overview of the final guidelines’ treatment of subjects’ consent in scientific research and identifies lingering issues posed by the final guidelines for scientific research.

Cookie Settings